Often the first entry into a patient’s body, intravenous therapy remains a common and critical intervention, but it is not without risks. Catheter-associated bloodstream infections (CABSIs) can be acquired at the time of the initial insertion or anytime throughout the duration of venous access — creating the potential for longer hospital stays, increased care costs and higher patient mortality. Incorporating evidence-based standards to IV insertion, care and maintenance can help protect against the factors that may lead to increased risk of bloodstream infection.
60% of all CABSIs originate from some form of vascular access.¹
1 in 4 patients who contract a CABSI will die.²
The cost to treat one CABSI averaged $45,000 USD per patient.³,⁴
The Infusion Nurses Society (INS) is a global authority on infusion therapy, setting stringent standards for practice. Every five years, INS releases updated, peer-reviewed standards that reflect the latest evidence to define and develop best practices for all clinical settings. 3M can help you stay up to date so you can help deliver better patient outcomes.
3M partners with you, offering a portfolio of innovative solutions to help you protect every IV catheter site — from insertion to removal — every time. From hand hygiene and barrier films to securement devices, disinfecting caps and more, our evidence-based products help you deliver compassionate care, protect patients, help prevent the risks of costly complications, and improve patient satisfaction.
3M takes a holistic approach to help you identify and reduce infection and transmission risks, navigate rapidly changing standards and guidelines, and provide science-based solutions that can help you protect patients, staff and everyone who enters your facility.
Thank you for connecting with 3M! We’ll be in touch with you shortly.
An error has occurred while submitting. Please try again later...